… phosphorylation changes and evaluate their applicability as early disease biomarkers. Impact on Diagnosis/Treatment of Parkinson’s disease:  Results from … be associated with disease status and disease progression into specific clinical outcomes in LRRK2-PD patients, and …

… and pharmacokinetics, with extensive experience in early phase drug discovery, lead optimization, project … to deliver high quality candidate molecules for entry into formal preclinical development. Since moving to Dundee …

… (PET) imaging studies will be performed in asymptomatic and early symptomatic mutation carriers using 11C-PBR28 (PBR28) … dopaminergic deficit and neuroinflammation. Relevance to Diagnosis/Treatment of Parkinson’s … mutation carriers and will provide preliminary insights into its relation to dopaminergic deficit and will inform …

… The microbiome is a growing area in Parkinson's research and The Michael J. Fox Foundation (MJFF) has … arising in the gut that contribute to Parkinson's. An early focus was on trying to understand the underlying … Parkinson's and without.  We have also funded research into potential treatments targeting the microbiome and …

… a movement disorder specialist discusses Parkinson's research and care through blogs and videos. Learn More … progress in treating the spectrum of Parkinson’s, from early diagnosis to advancing disease. It also discusses the latest …

… Michael J. Fox Foundation’s Patient Council, recalls the early days after her diagnosis. She describes the emotional and physical toll the … a number of reasons we don’t sufficiently participate in research; a lack of interest is not one of them. Part of the …